Price
Financials
Standalone, Rs crore| Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 73 | 129 | 89 | 133 | 112 | 214 | 104 | 256 | 107 |
| Expenses | 72 | 124 | 85 | 128 | 109 | 206 | 103 | 249 | 99 |
| Operating Profit | 1 | 5 | 4 | 5 | 3 | 8 | 1 | 8 | 8 |
| OPM % | 1.2% | 3.9% | 4.1% | 4.0% | 2.9% | 3.8% | 1.1% | 3.1% | 8% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 3 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | -1 | 4 | 1 | 4 | 2 | 6 | -1 | 6 | 4 |
| Tax % | -35% | 28% | 13% | 28% | 27% | 25% | -18% | 25% | 27% |
| Net Profit | -0 | 3 | 1 | 3 | 1 | 5 | -0 | 4 | 3 |
| EPS in Rs | -0.48 | 3.80 | 1.47 | 3.78 | 1.94 | 6.68 | -0.72 | 6.13 | 4.42 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 57 | 159 | 271 | 202 | 201 | 167 | 166 | 218 | 245 | 318 | 364 |
| Expenses | 56 | 157 | 263 | 195 | 197 | 163 | 160 | 209 | 236 | 309 | 348 |
| Operating Profit | 1 | 3 | 7 | 7 | 5 | 4 | 5 | 9 | 8 | 9 | 16 |
| OPM % | 1.6% | 1.6% | 2.7% | 3.4% | 2.2% | 2.6% | 3.3% | 4.0% | 3.5% | 2.9% | 4.4% |
| Other Income | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 4 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 |
| Profit before tax | 1 | 3 | 6 | 4 | 1 | 2 | 2 | 5 | 5 | 5 | 10 |
| Tax % | 33% | 31% | 34% | 31% | 28% | 28% | 28% | 25% | 28% | 26% | 26% |
| Net Profit | 0 | 2 | 4 | 3 | 1 | 1 | 1 | 4 | 4 | 4 | 7 |
| EPS in Rs | 4.00 | 18.52 | 37.44 | 5.67 | 2.02 | 2.16 | 2.14 | 5.23 | 5.73 | 5.96 | 10.55 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 5% | 7% | 10% | 6% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 20% | 17% | 19% | 14% | ||
| Compounded Profit Growth | 33% | 46% | 26% | 77% | ||
| Stock Price CAGR | % | % | 8% | -20% | ||
| Return on Equity | 16% | 14% | 14% | 18% |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 5 | 5 | 5 | 5 | 7 | 7 | 7 | 7 |
| Reserves | 2 | 4 | 7 | 6 | 7 | 8 | 10 | 23 | 27 | 31 | 37 |
| Borrowings | 5 | 10 | 20 | 14 | 20 | 22 | 25 | 22 | 21 | 22 | 35 |
| Other Liabilities | 20 | 72 | 60 | 65 | 56 | 46 | 37 | 47 | 73 | 81 | 76 |
| Total Liabilities | 27 | 87 | 89 | 91 | 88 | 81 | 77 | 100 | 127 | 141 | 155 |
| Fixed Assets | 2 | 2 | 8 | 8 | 8 | 12 | 14 | 16 | 22 | 24 | 24 |
| CWIP | 0 | 0 | 0 | 1 | 3 | 0 | 0 | 1 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 25 | 85 | 81 | 81 | 77 | 69 | 63 | 83 | 106 | 117 | 131 |
| Total Assets | 27 | 87 | 89 | 91 | 88 | 81 | 77 | 100 | 127 | 141 | 155 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -4 | 1 | 8 | 1 | 2 | 7 | -3 | 8 | 10 | 9 | |
| Cash from Investing Activity | 0 | -5 | -2 | -2 | -2 | -3 | -4 | -7 | -5 | -3 | |
| Cash from Financing Activity | 4 | 4 | -6 | 1 | -1 | -3 | 8 | -2 | -4 | -4 | |
| Net Cash Flow | 0 | -0 | -0 | 0 | -0 | 0 | 1 | -1 | 0 | 2 | |
| Free Cash Flow | -4 | 0 | 6 | -1 | 0 | 4 | -7 | 1 | 5 | 6 | |
| CFO/OP | -123% | 38% | 138% | 40% | 60% | 134% | -17% | 106% | 123% | 71% |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 92 | 121 | 65 | 77 | 88 | 72 | 73 | 75 | 86 | 65 | 55 |
| Inventory Days | 66 | 67 | 42 | 65 | 47 | 78 | 60 | 57 | 65 | 59 | 70 |
| Days Payable | 142 | 177 | 85 | 124 | 74 | 93 | 87 | 85 | 112 | 97 | 78 |
| Cash Conversion Cycle | 16 | 11 | 23 | 18 | 61 | 56 | 46 | 48 | 38 | 26 | 47 |
| Working Capital Days | 3 | 14 | 14 | 15 | 20 | 28 | 25 | 37 | 31 | 22 | 24 |
| ROCE % | 31% | 34% | 24% | 14% | 11% | 12% | 16% | 13% | 13% | 20% |
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Promoters | 73.37% | 73.37% | 73.37% | 73.37% | 73.42% | 73.42% | 73.42% |
| Public | 26.62% | 26.63% | 26.63% | 26.63% | 26.58% | 26.58% | 26.58% |
| No. of Shareholders | 660 | 652 | 742 | 625 | 512 | 468 | 453 |
Fundamentals
Market Cap₹ 65.1 Cr.
Current Price₹ 95.6
Stock P/E9.07
Book Value₹ 64.8
ROCE19.6 %
ROE17.6 %
Dividend Yield0.63 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)14%
Compounded Profit Growth (TTM)77%
Standalone figures.
Valuation
Market capRs 63 Cr
Enterprise valueRs 95 Cr
P/E (TTM)8.72x
Price to book1.42x
Price to sales0.17x
EV / EBITDA5.78x
EV / EBIT7.02x
EV / sales0.26x
Price to cash flow7.08x
Earnings yield11.46%
Dividend yield0.65%
P/E, 3-year average12.50x
P/B, 3-year average1.51x
P/E, 5-year average12.05x
P/B, 5-year average1.45x
Profitability
Operating margin (excl. other income)4.41%
Operating margin (incl. other income)4.54%
EBITDA margin4.54%
Pre-tax margin2.67%
Net profit margin1.97%
ROE17.63%
ROCE19.60%
ROA4.85%
ROE, 3-year average13.77%
ROCE, 3-year average15.13%
ROA, 3-year average3.77%
ROE, 5-year average13.49%
ROCE, 5-year average14.62%
ROA, 5-year average3.44%
ROIC (approx.)13.10%
Tax rate25.88%
Other income / net worth1.04%
Growth
Sales growth (latest year)14.37%
Profit growth (latest year)76.85%
Sales CAGR, 3 years18.67%
Sales CAGR, 5 years16.85%
Profit CAGR, 3 years26.34%
Profit CAGR, 5 years46.06%
Per share
EPS (TTM)Rs 10.55
EPS (latest year)Rs 10.55
EPS, 3-year averageRs 7.41
EPS, 5-year averageRs 6.08
Book value per shareRs 64.79
Sales per shareRs 534.05
Cash flow per shareRs 13.00
Free cash flow per shareRs 8.81
Dividend per share (latest year)Rs 0.60
Dividend per share, 3-year averageRs 0.53
Dividend per share, 5-year averageRs 0.46
Dividends
Dividend payout5.71%
Dividend payout, 3-year average7.58%
Dividend payout, 5-year average6.88%
Efficiency
Asset turnover2.34x
Fixed asset turnover15.38x
Inventory turnover5.37x
Inventory days68 days
Debtor days55 days
Debtors turnover6.64x
Creditor days78 days
Cash conversion cycle47 days
Working capital days24 days
Leverage
Total debtRs 35 Cr
Cash and bankRs 3 Cr
Net debtRs 33 Cr
Debt to equity0.80x
Net debt / EBITDA1.98x
Interest coverage3.49x
Owners' fund to total sources28.42%
Debt to assets22.81%
Cash flow
Cash from Operating Activity (latest year)Rs 9 Cr
Cash from Investing Activity (latest year)Rs -3 Cr
Cash from Financing Activity (latest year)Rs -4 Cr
Net Cash Flow (latest year)Rs 2 Cr
Free cash flow (latest year)Rs 6 Cr
FCFE (approx.: FCF + change in debt)Rs 20 Cr
Cash from ops / profit, 5 years1.55x
Sales to cash flow41.08x
Statement figures
Net sales (TTM)Rs 364 Cr
Net sales (latest year)Rs 364 Cr
Operating profit excl. other income (latest year)Rs 16 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 17 Cr
PBDT (TTM)Rs 13 Cr
Profit before tax (TTM)Rs 10 Cr
Tax (latest year)Rs 3 Cr
Net profit (TTM)Rs 7 Cr
Net profit (latest year)Rs 7 Cr
Depreciation (TTM)Rs 3 Cr
Interest (TTM)Rs 4 Cr
Cost of goods sold (latest year)Rs 339 Cr
Total expenditure (latest year)Rs 348 Cr
Total income (latest year)Rs 364 Cr
Share capitalRs 7 Cr
ReservesRs 37 Cr
Shareholders' fundsRs 44 Cr
Total assetsRs 155 Cr
Net blockRs 24 Cr
InvestmentsRs 0 Cr
ReceivablesRs 55 Cr
InventoryRs 63 Cr
Other liabilitiesRs 76 Cr
Shares outstanding (crore)0.68
Ownership
Promoter holding73.42% (+0.05 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 8.7 is the lowest in its own 3.8-year history
(median 17.3, low 8.7, high 38.8).
P/B 1.42 is at the 7th percentile (median 2.00).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | ARISTO | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -17.9% | -2.8% | -15.1 pts |
| 1 month | -3.2% | -6.8% | +3.6 pts |
| 3 months | -3.2% | -7.6% | +4.5 pts |
| 6 months | -33.8% | +0.4% | -34.2 pts |
| 1 year | -33.3% | -9.9% | -23.4 pts |
| 2 years | +20.7% | -13.6% | +34.3 pts |
| 3 years | +16.5% | +14.2% | +2.3 pts |
Red flags
F-score 7 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2026Sales ₹107 Cr -4.5% vs Mar 2024.
Net profit ₹3 Cr +200.0%.
Against our estimate for Mar 2026: sales -3.2%, profit +121.2% beat.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| UPL Ltd | 45,402 | 23.0 | 10.1 % |
| P I Industries Ltd | 34,725 | 32.2 | 15.0 % |
| Sumitomo Chemical India Ltd | 21,521 | 37.7 | 23.5 % |
| Bayer CropScience Ltd | 16,191 | 22.1 | 29.1 % |
| Sharda Cropchem Ltd | 6,509 | 10.4 | 30.2 % |
| Dhanuka Agritech Ltd | 4,148 | 15.5 | 23.8 % |
| Rallis India Ltd | 3,882 | 17.0 | 14.1 % |
| Bhagiradha Chemicals & Industries Ltd | 3,128 | 114 | 4.53 % |
| NACL Industries Ltd | 3,101 | 120 | 8.13 % |
| GSP Crop Science Ltd | 2,198 | 21.0 | 18.9 % |
| Insecticides India Ltd | 1,706 | 13.6 | 15.8 % |
| Bharat Rasayan Ltd | 1,673 | 12.0 | 16.1 % |
| Astec Lifesciences Ltd | 1,552 | -5.44 % | |
| India Pesticides Ltd | 1,533 | 14.2 | 16.6 % |
| Meghmani Organics Ltd | 1,458 | 22.7 | 6.71 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Less than 100 unique PAN traded in previous 30 daysMandatory Market making period in SME scrip is overSME scrip is not regularly traded
Quick answers
What is the market cap of Aristo Bio-Tech & Lifescience Ltd?
Aristo Bio-Tech & Lifescience Ltd (ARISTO) has a market capitalisation of Rs 65.1 Cr. at the 2026-10-01 close.
What is the P/E ratio of Aristo Bio-Tech & Lifescience Ltd?
Aristo Bio-Tech & Lifescience Ltd trades at a P/E of 9.07 on trailing twelve-month profit, at the 2026-10-01 close.
What were Aristo Bio-Tech & Lifescience Ltd's latest quarterly results?
In the Mar 2026 quarter, Aristo Bio-Tech & Lifescience Ltd sales was Rs 107 Cr (-4.5% vs Mar 2024) and net profit was Rs 3 Cr.
What is the 52-week high and low of Aristo Bio-Tech & Lifescience Ltd?
The 52-week high is Rs 136.00 and the 52-week low is Rs 74.30.